FIRST-LINE MOBOCERTINIB VERSUS PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH EGFR EXON 20 INSERTION-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER IN THE PHASE III EXCLAIM-2 TRIAL
/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da LuisaAIGOM
Associazione italiana gruppi oncologici multidisciplinari
Via Mameli 3, 16122 Genova
mail: info@aigom.it
segreteria@aigom.it
Health Media Srl
Carlo Buffoli e Gino Di Mare
mail: info@healthmedia.it
C.F. 95237450101